MicroPhage, Inc. announced today that Don Mooney has been named as the new Chief Executive Officer of the company effective February 3, 2011. "The board selected Don on the basis of his deep diagnostics experience and proven leadership abilities particularly in launching new products, handling regulatory issues and creating effective strategic partnerships," said Gary Mesch, Executive Chairman of the Board for MicroPhage. "Don seems to fit very well with the MicroPhage team and brings strong decision-making skills and vision to guide the company through these next critical months and years as we commercialize the business. We are very pleased that he has chosen to join the team."
MicroPhage, Inc. is working to be a global leader in developing rapid, easy-to-use diagnostic products for bacterial identification and antibiotic susceptibility/resistance testing. Using its proprietary Bacteriophage Amplification platform, the Company has developed patented processes that are a platform for rapid, easy-to-use, inexpensive diagnostic and screening tests. The technology platform resembles a home pregnancy test with twin, rapid detectors. The platform does not require any instrumentation and is simple to operate, enabling microbiology testing outside of traditional laboratory settings.